Sophia Genetics/SOPH

$4.86

-2.79%
-
1D1W1MYTD1YMAX

About Sophia Genetics

Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.

Ticker

SOPH

Sector

Technology

Trading on

NASDAQ

Industry

Software & Programming

CEO

Jurgi Camblong

Employees

449

Headquarters

Rolle, Switzerland

Sophia Genetics Metrics

BasicAdvanced
$326.51M
Market cap
-
P/E ratio
-$1.22
EPS
-
Beta
-
Dividend rate
$326.51M
$7.37
$2.13
55.73K
4.156
3.974
10.349
12.283
-20.39%
-35.1%
-44.93%
-40.76%
5.235
2.154
2.628
31.14%
10.68%
29.98%

What the Analysts think about Sophia Genetics

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 3 analysts.
78.4% upside
High $10.00
Low $8.00
$4.86
Current price
$8.67
Average price target

Sophia Genetics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-141.17% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$17M
4.29%
Net income
$-24M
73.91%
Profit margin
-141.17%
66.75%

Sophia Genetics Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 37.04%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.31
-$0.33
-$0.21
-$0.37
-
Expected
-$0.32
-$0.31
-$0.32
-$0.27
-$0.28
Surprise
-2.02%
7.7%
-35.05%
37.04%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Sophia Genetics stock?

Sophia Genetics (SOPH) has a market cap of $326.51M as of April 16, 2024.

What is the P/E ratio for Sophia Genetics stock?

The price to earnings (P/E) ratio for Sophia Genetics (SOPH) stock is 0 as of April 16, 2024.

Does Sophia Genetics stock pay dividends?

No, Sophia Genetics (SOPH) stock does not pay dividends to its shareholders as of April 16, 2024.

When is the next Sophia Genetics dividend payment date?

Sophia Genetics (SOPH) stock does not pay dividends to its shareholders.

What is the beta indicator for Sophia Genetics?

Sophia Genetics (SOPH) does not currently have a Beta indicator.

What is the Sophia Genetics stock price target?

The target price for Sophia Genetics (SOPH) stock is $8.67, which is 78.4% above the current price of $4.86. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Sophia Genetics stock

Buy or sell Sophia Genetics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing